Skip to main content
Caplight Logo









Studia

Studia

Private
OverijseHealthcare & Life Scienceshttps://studia.health/

Company Overview

Studia is a health-tech company that provides an AI-powered medical writing platform designed to assist clinical research professionals in drafting and managing regulatory documents.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Document Management, Medical AI, Compliance, NLP & Conversational AI

Business Model

B2B

Customer Profile

Subscription SaaS

AI Layer

Application

Keywords

medical writingclinical documentationregulatory document automationclinical trial softwareGood Clinical PracticeGCPAI medical writingclinical research organizationCROclinical study reportsregulatory compliancemedtechAI copilot for pharmaclinical trial automationSaaS for life sciences

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Studia Comparables

Compare Studia with similar companies based on industry and business-model similarity.

Studia comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Skaldi, Inc.
87%
Genactis
86%
Narrativa
84%

Studia Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Key People

Founding team and executive leadership

Marc VERHAEREN

co-Founder & CEO

Founding Team

Studia Filings

Explore SEC and related filing metadata, where available.

Studia filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Studia's valuation, stock price, and market status.

Is Studia a public or private company?

Studia is a private company.

What is the current stock price of Studia?

Studia is a private company, so its shares have no public market price. Caplight tracks Studia's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Studia worth (valuation)?

Valuation information for Studia is not publicly available.

Can I buy Studia stock?

Studia shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Studia's last funding round?

Funding round information for Studia is not publicly available.

Who are the main investors in Studia?

Investor information for Studia is not publicly disclosed.

Will Studia IPO soon?

No public IPO plans have been announced for Studia.

How can I track Studia secondary market activity?

Caplight tracks bids, offers, and trades in Studia's shares on secondary markets.

Firmographic Details

HeadquartersOverijse
Employee Range3
Year FoundedN/A
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?